Company Tiziana Life Sciences PLC London S.E.
Equities
GB00B28XMY25
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
|
28/06 | Tiziana Life Sciences Gets $3.4 Million in Funding for Neurodegenerative Disease Studies | MT |
28/06 | Transcript : Tiziana Life Sciences Ltd - Special Call |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11/98/11 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Matthew Davis
COO | Chief Operating Officer | - | 01/22/01 |
Paul Spencer
IRC | Investor Relations Contact | - | 01/22/01 |
William Clementi
PRN | Corporate Officer/Principal | - | 01/23/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 01/20/01 |
Willy Simon
BRD | Director/Board Member | 72 | 01/15/01 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11/98/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 194,612,289 | 63,738,859 ( 32.75 %) | 0 | 32.75 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ACCUSTEM SCIENCES, INC. 11.80% | 1,337,970 | 11.80% | 628,846 $ |
Company contact information
![address Tiziana Life Sciences PLC](https://cdn.zonebourse.com/static/address/4007585.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- TLSA Stock
- Stock
- Company Tiziana Life Sciences PLC